iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by NTV Asset Management LLC

NTV Asset Management LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,996 shares of the financial services provider’s stock after selling 2,404 shares during the period. iShares Biotechnology ETF makes up 1.2% of NTV Asset Management LLC’s holdings, making the stock its 17th biggest position. NTV Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $7,199,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Glass Jacobson Investment Advisors llc grew its position in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares in the last quarter. Values First Advisors Inc. purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at $43,000. Tennessee Valley Asset Management Partners purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $44,000. Column Capital Advisors LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $49,000. Finally, Massmutual Trust Co. FSB ADV grew its holdings in shares of iShares Biotechnology ETF by 164.2% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 225 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB traded up $2.31 on Friday, hitting $132.96. The stock had a trading volume of 1,804,184 shares, compared to its average volume of 1,700,513. The company has a fifty day moving average price of $133.61 and a two-hundred day moving average price of $129.99. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.